2170137-61-6
2170137-61-6
Chemical Structure
GSK-3685032
- CAS No.: 2170137-61-6
- Formula:C22H24N6OS
- Molecular Weight:420.53
IUPAC Name: 2-((6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl)thio)-2-phenylacetamide
InChIKey: KNKHRZYILDZLRE-UHFFFAOYSA-N
SMILES: N#CC1=C(SC(C2=CC=CC=C2)C(N)=O)N=C(N3CCC(CC3)N)C(C#N)=C1CC
Biological Activity: GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK-3685032 | 99.41% | GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GSK-3685032 (Standard) | ≥98% | GSK-3685032 (Standard) is the analytical standard of GSK-3685032 (HY-139664). This product is intended for research and analytical applications. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
